Gen AI and sensitive data in healthcare – what does regulation require from developers?

FAIR EDIH, AI Regu and LUMI AI Factory are starting Health Technology Roundtables, a four-part series. The first session takes place on Thursday 26 November 2026 in Otaniemi.
The intended use of a health GenAI solution decides which requirements apply to it. That is why risk classification and the legal basis for using sensitive data are worth settling at the start of development.
The first session covers the regulation that affects GenAI development in healthcare and what it means in practice. Topics include how intended use shapes the applicable requirements, risk assessment, and the legal questions around using sensitive data.
The experts are Sandra Liede (Laissa) and Kirsi Talman (Sailab – MedTech Finland). Their talks are followed by an open discussion with participants, with room for your own questions.
The event is for companies, experts and innovators developing GenAI solutions for healthcare.
Practical information
Time: Thursday 26 November 2026, 8:30–12:00. Breakfast and registration start at 8:30, and the programme starts at 9:00.
Venue: LUMI AI Factory Hub, Maarintie 8, Otaniemi, Espoo
Language: Finnish
Price: Participation is free. It counts as de minimis aid of €200 per participant for your company, and the signed de minimis form must be returned before the event.
Seats are limited.
Register: https://www.lyyti.fi/reg/AIRegu_LUMI_1
Join online: https://teams.microsoft.com/meet/333456153955650?p=PbjtZNLmW9HGvt4lhY
26 marraskuun @ 8:30 am – 12:00 pm
